Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-23T12:44:57.543Z Has data issue: false hasContentIssue false
  • English
  • Français

Tardive dyskinesia on low dose risperidone

Published online by Cambridge University Press:  13 June 2014

Tolulope Alugo ,
Finian Kelly ,
Ann O'Grady-Walsh  and
Peter Whitty
Tolulope Alugo*
Affiliation:
Tallaght Adult Mental Health Services, Adelaide & Meath Hospital, Tallaght, Dublin 24, Ireland
Finian Kelly
Affiliation:
Tallaght Adult Mental Health Services, Adelaide & Meath Hospital, Tallaght, Dublin 24, Ireland
Ann O'Grady-Walsh
Affiliation:
Tallaght Adult Mental Health Services, Adelaide & Meath Hospital, Tallaght, Dublin 24, Ireland
Peter Whitty
Affiliation:
Tallaght Adult Mental Health Services, Adelaide & Meath Hospital, Tallaght, Dublin 24, Ireland
*
*Correspondence E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Tardive dyskinesia is a neurological disorder characterised by involuntary and purposeless movements affecting any part of the body. These movements typically occur in the oro-facial area and the patient is usually unaware of them. There are inconsistent findings in the literature on the risk factors for developing tardive dyskinesia. Nevertheless, previous reports indicate that tardive dyskinesia is more common in female patients, patients with a history of alcohol and substance misuse, affective disorders, and intellectual disability. The dose, class and duration of antipsychotic nmedication may also be independent risk factors. We report on the case of a patient who developed tardive dyskinesia on a low dose of the second generation antipsychotic risperidone.

Type
Case Reports
Information
Irish Journal of Psychological Medicine , Volume 27 , Issue 1 , March 2010 , pp. 45 - 46
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Tachikawa, H, Suzuki, T, Kawanishi, Y, Hori, M, Hori, T, Shirashi, H. Tardive dyskinesia provoked by concomitantly administered risperidone. Psychiatry Clin Neurosci 2000 54; 503–505CrossRefGoogle ScholarPubMed
2.Kumar, S, Malone DM Risperidone implicated in the onset of tardive dyskinesia in a young woman. Post Grad Med J 2000; 76:316–317.CrossRefGoogle ScholarPubMed
3.Suzuki, EMichiyuki, O, Yoshiko, Y, Hitoshi, MTardive dyskinesia with risperidone and anticholinergics. Am J Psychiatry 2002; 159: 1948CrossRefGoogle ScholarPubMed
4.Anand, VS, Dewan, MJWithdrawal emergent dyskinesia in a patient on risperidone undergoing dosage reduction. Ann Clin Psychiatry 1996; 8(3): 179–82CrossRefGoogle Scholar
5.Lykouras, I, Yannakis, R, Hatzimanolis, J, Christodoulou, GNTardive dyskinesia dose reduction on risperidone. Eur Psychiatry 1999; 14: 245–247CrossRefGoogle ScholarPubMed
6.Miller, LJWithdrawal emergent dyskinesia in patients taking risperidone and citalopram. Ann pharmacother 2000; 34(2): 269.CrossRefGoogle ScholarPubMed
7.Kamatsu, S, Kirino, E, Inoue, Y, Arai, H. Risperidone withdrawal related respiratory dyskinesia-A case diagnosed by spirography and fibroscopy. Clin Neuropharmacol 2005; 28: 90–93.CrossRefGoogle Scholar
8.Guy W ECDU Assessment manual for psychopharmacology; publication ADM 76-338 Washington DC, US Dept of Health, Education and Welfare 1976, pp 534–537Google Scholar